Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence
Clinical trial NCT02681302 · TERMINATED
Trial details
- NCT number
- NCT02681302
- Sponsor
- Hackensack Meridian Health
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-07
- Primary completion
- 2024-05-10
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.